HUNG GUANG BIOTECH CO LTD has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in China, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are OURO FINO PARTICIPACOES E EMPREENDIMENTOS S A, FREEDOM HEALTH LLC and NEOPHARMA JAPAN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Russian Federation | 1 | |
#9 | Taiwan | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Fodder | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chang Hung-Shu | 8 |
#2 | Yu Tse-Min | 8 |
#3 | Hung-Shu Chang | 1 |
#4 | Tse-Min Yu | 1 |
#5 | Chang Hung Shu | 1 |
#6 | Yuj Tszemin | 1 |
#7 | Chan Khunshu | 1 |
#8 | Yu Tse Min | 1 |
Publication | Filing date | Title |
---|---|---|
EP3219722A1 | Modified colostrum protein and application thereof | |
CN107188946A | Serum colostrum protein and its application through modification |